EU: no re-dosing [Outliers]

posted by swapnil.kuche – 2011-03-10 07:39 (4768 d 03:03 ago) – Posting: # 6735
Views: 7,508

Dear HS,

Thanks a lot for for your prompt reply.

❝ How did you judge that the subject was an outlier?


On review of p'cokinetic data it was observed that one of subject is showing highest T/R ratio for Cmax and AUC. So we just recalculate 90% CI by excluding that subject and those results were within acceptance limit. No specific outlier test is applied here.

Infact this is about fed biequivalence study for gastro-resistant formulation and importanly we have positive results for fasting study for the same formulation.

What should be our future strategy in the same regard.

Regards,
Swapnil


Edit: Original quote restored. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
115 visitors (0 registered, 115 guests [including 8 identified bots]).
Forum time: 10:43 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5